维普期刊资源整合服务平台（V6.5）

41篇 您的检索式：作者名="Frye RF"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Interaction of sorafenib andcytochrome P450 isoenzymes in patients with advanced melanoma : aphase I/II pharmacokinetic interaction study显示文摘	Flaherty KT Lathia C Frye RF	2011	Cancer ChemotherPharmacol2011，68，：	1
2	Determinants of vancomycin clearance by continuous venovenous heamofihration and continuous venovenous haemodialysis 显示文摘	JOY MS MATZKE GR FRYE RF	1998	Am J Kidney Dis1998，31，6：	1
3	Pharmacokinetics of abecarnil in patients with renal insuffieieney显示文摘	Karara AH Frye RF Hayes PE	1996	Clin Pharmaeol Ther1996，59，5：	1
4	Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis显示文摘	Joy MS Matzke GR Frye RF	1998	Am J Kidney Dis1998，31，6：	1
5	Determinants of ceftazidime clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis显示文摘	Matzke GR Frye RF Joy MS	2000	Antimicrob Agents Chemother2000，44，6：	1
6	ESRD impairs nonrenal clearance of fexofenadine but not midazolam显示文摘	Nolin TD Frye RF Le P	2009	J Am Soc Nephrol2009，20，10：	1
7	Validation of the five-drug 'Pittsburgh cocktail' approach for assessment of selective regulation of drug-metabolizing enzymes显示文摘	Frye RF Matzke GR Adedoyin A	1997	Clin Phannacol Ther1997，62，4：	1
8	Determinants of ceftriaxone clearance by continuous venovenous hemofiltration and hemodialysis显示文摘	Matzke GR Frye RF Joy MS	2000	Pharmaeotherapy2000，20，6：	1
9	Probing the world of cytochrome P450 enzymes 显示文摘	Frye RF	2004	Mollnterv2004，4，：	1
10	Inhibition of intestinal and hepatic glu- cumnidation of mycophenolic acid by Ginkgo biloba extract and fiavonoids显示文摘	Mohamed MEF Frye RF	2010	Drug Metabol Disposit2010，35，2：	1
11	Validation of the five-drug 'Pittsburgh cocktail' approach for assessment of selective regulation of drug-metabolizing enzymes显示文摘	Frye RF Matzke GR Adedoyin A	1997	Clin Pharmacol Ther1997，62，4：	1
12	Probing the world of cytochrorae P450 enzymes显示文摘	Frye RF	2004	Mol Interv2004，4，：	1
13	Probing the world of cytochrome P450 enzymes显示文摘	Frye RF	2004	Mol Interv2004，4，3：	1
14	Pharmacometabolomics re- veals racial differences in response to atenolol treatment显示文摘	Wikoff WR Frye RF Zhu H	2013	PLoS One2013，8，57：	1
15	Determination of famotidine in human plasma and urine by high-performance liquid chromatography显示文摘	Dowling TC Frye RF	1999	J Chromatogr B1999，732，：	1
16	Validation of the five- drug 'Pittsburgh cocktail' approach for assessment of selective regulation of drug - metabolizing enzymes显示文摘	Frye RF Matzke GR Adedoyin A	1997	Clin Pharmacol Ther1997，62，4：	1
17	Simplified method for determination of rosiglitazone in human plasma显示文摘	HRUSKA MW FRYE RF	2004	J Chromatogr B Analyt Technol Biomed Life Sci2004，803，2：	1
18	The effect of renal insufficiency and hemodialysis on the pharmacokinetics of nalmefene 显示文摘	Matzke GR Frye RF Alexander AC	1996	J Clin Pharmacol1996，36，2：	1
19	Plasma levels of TNF-alpha and IL-6 are inversely related to cytochrome P450-dependent drug metabolism in patients with congestive heart failure显示文摘	Frye RF Schneider VM Frye CS	2002	J Card Fail2002，8，5：	1
20	Inhibition of intestinal and hepatic glucuronidation of mycophenolic acid by Ginkgo biloba extract and flavonoids显示文摘	Mohamed MF Frye RF	2010	Drug Metab Dispos2010，38，27：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示